Table 1.
Patient characteristics
| Patient Number* (Age, sex) | ART regimen | Duration (months) | CD4+ T-cell count (cells/μL) | |||
|---|---|---|---|---|---|---|
| Total time under treatment | Time with HIV-1 RNA < 50 copies/mL | Time in treatment after IVIG administration | Current | Nadir | ||
| 1 (65,M) | ABC+3TC+EFV | 103 | 96.1 | 24.3 | 470 | 180 |
| 2 (53,M) | TDF+FTC+EFV | 147.6 | 105.3 | 21.6 | 790 | 200 |
| 3 (35,M) | ABC+ZDV+3TC+LPV/r | 76.6 | 73.6 | 20.5 | 180 | 20 |
| 4 (36,F) | ABC+3TC+ATV/r | 76 | 71 | 21.5 | 430 | 50 |
| 5 (58,M) | 3TC+ABC+LPV/r | 145.6 | 84.3 | 11.7 | 150 | 40 |
| 6 (36,M) | ZDV+3TC+EFV | 132.7 | 48.3 | 12.4 | 240 | 120 |
| 7 (43,M) | TDF+FTC+LPV/r | 99 | 32 | 10.6 | 550 | 40 |
| 8 (45,M) | 3TC+ABC+NVP | 95.4 | 87.2 | 12.1 | 310 | 30 |
| 9 (43,M) | TDF+FTC+ATV/r | 92.6 | 79.3 | 12.3 | 640 | 90 |
| Median | 99 | 79.3 | 12.4 | 430** | 50 | |
| C1 (38,F) | 3TC+ABC+ATV/r | 56.7 | 55.9 | 910 | 176 | |
| C2 (45,M) | ZDV+3TC+SQV/r | 88.4 | 75.1 | 730 | 230 | |
| C3 (26,F) | 3TC+ABC+EFV | 47 | 46.2 | 470 | 240 | |
| C4 (47,F) | TDF+FTC+LPV/r | 84.6 | 80 | 1000 | 20 | |
| C5 (44,F) | ETV+ATV/r+RAL | 94.7 | 80.4 | 530 | 42 | |
| C6 (42,M) | ZDV+FTC+EFV | 55.8 | 50.3 | 430 | 80 | |
| C7 (39,F) | 3TC+ABC+ATV/r | 104 | 110.2 | 480 | 17 | |
| C8 (61,M) | TDF+FTC+EFV | 134 | 78.5 | 530 | 340 | |
| C9 (42,F) | 3TC+ABC+LPV/r | 132 | 128.6 | 510 | 40 | |
| C10 (56,M) | ZDV+3TC+ABC | 153.4 | 140.4 | 750 | 45 | |
| C11 (36,F) | 3TC+ABC+LPV/r | 100.4 | 93.1 | 700 | 200 | |
| C12 (43,M) | 3TC+ABC+LPV/r | 32.1 | 24.3 | 550 | 190 | |
| C13 (46,F) | TDF+FTC+EFV | 83.6 | 71.9 | 330 | 40 | |
| C14 (37,F) | ZDV+3TC+LPV/r | 62.3 | 58.3 | 720 | 140 | |
| Median | 86.5 | 76.8 | 540** | 110 | ||
* Controls are denoted C1-C14
** CD4+ T-cell count differed between groups (p = 0.05)
ABC, abakavir; ATV/r, atazanavir/ritonavir; EFV, efavirenz; ETV, entecavir; FTC, emtricitabine; LPV/r, lopinavir/ritonavir; NVP, nevirapine; RAL, raltegravir; SQV/r, saquinavir/ritonavir; TDF, tenofovir; ZDV, zidovudine; 3TC, lamivudine;